OVARIAN CANCER and US: patient safety

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Showing posts with label patient safety. Show all posts
Showing posts with label patient safety. Show all posts

Monday, June 18, 2012

Imperfect measure of hospital safety - CIHI



Imperfect measure of hospital safety

Imperfect measure of hospital safety

  1. CMAJ
The failure to include hospital-acquired infections or medication errors as a performance indicator limits the utility of the Canadian Institute for Health Information’s (CIHI) new hospital benchmarking tool, critics say....


Figure

Friday, May 25, 2012

Surgical site infection prevention: a survey to identify the gap between evidence and practice in University of Toronto teaching hospitals - Can J Surg. 2012 Jun 1



Blogger's Note: surgical site infections safety checklist: WHO (World Health Organization) program in patient safety

Surgical site infection prevention: a survey to identifythe gap between evidence and practice in University of Toronto teaching hospitals

 "Surgical site infections (SSIs) are the most common
complication following surgery, with reported rates
ranging from 5% to 30%.1 The attributable morbidity
and mortality is significant, with patients who experience
SSIs being 60% more likely to spend time in the
intensive care unit, 5 times more likely to be readmitted to
hospital and twice as likely to die than patients without
SSIs.2 Whereas many risk factors for the development of
SSIs are related to patient characteristics that cannot be easily
modified, there are a variety of system or hospital factors
that can be manipulated. These include improper selection
and administration of antibiotic prophylaxis, intraoperative
hypothermia and intraoperative hyperglycemia.3
Despite clear evidence and guidelines to direct SSI prevention
strategies, compliance is uniformly poor......

Tuesday, April 17, 2012

open access: What do surgical trainees think about patient safety culture, and is this different from their consultants?



What do surgical trainees think about patient safety culture, and is this different from their consultants?

Abstract

Introduction Little is known about the patient safety culture within surgical departments in UK hospitals. What has been done to date is to survey only permanent senior staff opinion of the safety culture in their institution. This study surveyed both consultant and trainee views on perceived patient safety and compared the results between these two groups. 

Material and methods The previously validated Team Work and Safety Climate Questionnaire was configured in Survey Monkey format and sent to all surgical trainees and consultant surgeons in the South West Strategic Health Authority. Two reminders were sent to achieve as high a return rate as possible. 

Results Two hundred and ninety-six replies were received. Forty-four percent of trainees and 30% of consultants responded to the survey. Consultants consistently rated a higher safety culture than surgical trainees. Only 2.9% of trainees believe their patient safety concerns would be acted upon by hospital management. There is notable variation in perceived patient safety culture between hospitals. 

Conclusion This study has suggested that the patient safety culture in hospitals, within a Strategic Health Authority, is variable and sub-optimal when viewed by surgical trainees and their consultants. This study also provides some evidence that the perception of patient safety in an organization varies according to clinical experience. As trainees deliver a great deal of clinical care, surveys of safety culture should include this group. As perceived patient safety culture is correlated to clinical outcomes, validated safety surveys might form part of the assessment of a hospital's performance, along with outcome and patient satisfaction.

Introduction

Medical errors are a major cause of mortality and morbidity. The National Patient Safety Agency (NPSA) estimates that 10% of all hospital admissions suffer an adverse event defined as a medical error that results in harm to the patient. One percent of all admissions die as a result of an adverse event. In practice this means that in England and Wales 300,000 adverse events and 30,000 deaths are recorded every year. This figure of 30,000 deaths a year is a greater number of deaths than the combined annual mortality from colorectal, prostate and breast cancer.1 Even these striking figures may be underestimating the extent of the problem because recent studies in the surgical literature2 indicate the adverse event rate could even be as high as 20%...........

Tuesday, April 03, 2012

abstract: Study: Vast Majority of C difficile Infections Occur in Medical Settings, April 4, 2012, Voelker 307 (13): 1356 — JAMA



Study: Vast Majority of C difficile Infections Occur in Medical Settings, April 4, 2012

    Most Clostridium difficile infections, often assumed to be community acquired, actually occur in medical settings, according to recent data from the Centers for Disease Control and Prevention (CDC). 

    In fact, 94% of the potentially fatal infections are in people who recently received care in facilities such as hospitals, nursing homes, physicians' offices, and outpatient surgical centers. To stem the rising tide of C difficile infections, CDC officials say hospitals and other health care settings need greater adherence to infection control practices and improved communication to notify each other whenever they transfer an infected patient. 

    “These infections are now a patient safety concern everywhere medical care is given,” said Clifford McDonald, MD, a CDC medical epidemiologist and lead author of the study in the Morbidity and Mortality Weekly Report (http://tinyurl.com/7dh83hh). “About 25% of C difficile infections first show symptoms among patients in hospitals; 75% first show symptoms among patients in nursing …"


    Thursday, March 29, 2012

    (2nd article) Medicare's Readmissions-Reduction Program — A Positive Alternative — NEJM



    Medicare's Readmissions-Reduction Program — A Positive Alternative — NEJM

    Hospital readmissions are receiving increasing attention as a largely correctable source of poor quality of care and excessive spending. According to a 2009 study, nearly 20% of Medicare beneficiaries are rehospitalized within 30 days after discharge, at an annual cost of $17 billion.1 Causes of avoidable readmissions include hospital-acquired infections and other complications; premature discharge; failure to coordinate and reconcile medications; inadequate communication among hospital personnel, patients, caregivers, and community-based clinicians; and poor planning for care transitions........

    Wednesday, March 28, 2012

    Consumer Reports targets medical devices' safety - latimes.com



     Blogger's Note: search blog for other posts regarding 'surgical mesh' issues/concerns

    Consumer Reports targets medical devices' safety - latimes.com

    "In a report issued Wednesday the consumer magazine also expressed concerns about risks related to surgical mesh, metal hips and certain cardiac devices. It highlighted how the federal government allows some products to be sold with little or no advance safety testing......

    Saturday, March 17, 2012

    abstract: Patient Selection for Oncology Phase I Trials: A Multi-Institutional Study of Prognostic Factors [Phase I and Clinical Pharmacology]



    Patient Selection for Oncology Phase I Trials: A Multi-Institutional Study of Prognostic Factors [Phase I and Clinical Pharmacology]:

    Purpose
    The appropriate selection of patients for early clinical trials presents a major challenge. Previous analyses focusing on this problem were limited by small size and by interpractice heterogeneity. This study aims to define prognostic factors to guide risk-benefit assessments by using a large patient database from multiple phase I trials.

    Patients and Methods
    Data were collected from 2,182 eligible patients treated in phase I trials between 2005 and 2007 in 14 European institutions. We derived and validated independent prognostic factors for 90-day mortality by using multivariate logistic regression analysis.

    Results
    The 90-day mortality was 16.5% with a drug-related death rate of 0.4%. Trial discontinuation within 3 weeks occurred in 14% of patients primarily because of disease progression. Eight different prognostic variables for 90-day mortality were validated: performance status (PS), albumin, lactate dehydrogenase, alkaline phosphatase, number of metastatic sites, clinical tumor growth rate, lymphocytes, and WBC. Two different models of prognostic scores for 90-day mortality were generated by using these factors, including or excluding PS; both achieved specificities of more than 85% and sensitivities of approximately 50% when using a score cutoff of 5 or higher. These models were not superior to the previously published Royal Marsden Hospital score in their ability to predict 90-day mortality.

    Conclusion
    Patient selection using any of these prognostic scores will reduce non–drug-related 90-day mortality among patients enrolled in phase I trials by 50%. However, this can be achieved only by an overall reduction in recruitment to phase I studies of 20%, more than half of whom would in fact have survived beyond 90 days.

    Friday, March 16, 2012

    Public Disclosure of Hospital Infection Rates Vary by State (surgical site infections) - patients “walking in blind”



    Public Disclosure of Hospital Infection Rates Vary by State


    Public Disclosure of Hospital Infection Rates Vary by State

    Released: 3/16/2012 12:20 PM EDT
    Source: Johns Hopkins Medicine
     
    --Johns Hopkins study finds patients “walking in blind” with little access to quality and outcomes data

    Newswise — Only 21 states require public reporting of hospital data on surgical site infections and, even when disclosure is mandated, the information is often not easily accessible to patients who could use it to make decisions about their medical care, according to new Johns Hopkins research.
    The research findings suggest that a haphazard, state-by-state system for reporting these critical measures of health care quality isn’t working and that only national guidelines governing disclosure can paint a clear picture of how well hospitals are doing at preventing patient harm, the researchers say.
    Reporting accurate data on measures such as rates of surgical site infections can be an inexpensive way to actually reduce them, the authors note in their study published online in the Journal for Healthcare Quality.
    When patients have access to this information and use it to take their business to hospitals with lower infection rates for select operations, the researchers say, hospitals with higher infection rates will have financial and reputational incentives to quickly find ways to do better.
    A lot of information is not available to the public and, if it were, hospitals would be motivated to improve,” says study leader Martin Makary, M.D., M.P.H., an associate professor of surgery at the Johns Hopkins University School of Medicine. “Right now, a hospital can have high complication rates, high readmission rates and high infection rates, but because patients can’t look up this information, they’re essentially walking in blind.”
    One example of the impact of such transparency occurred in New York State two decades ago, Makary said. Rates of mortality from coronary artery bypass surgery varied widely among hospitals before the state began requiring public reporting of death rates from the procedure. Four years into mandatory reporting requirements, average hospital death rates from the operation fell by 41 percent. Makary says he thinks one reason for the precipitous drop is that “poorly performing hospitals had an incentive to look better to consumers making health care decisions.”
    Researchers estimate that surgical site infections occur in up to 25 percent of patients after major surgical procedures and are estimated to cause more than 8,000 deaths a year. The occurrence of a surgical site infection is increasingly recognized to be largely preventable and, as a result, rates are being used as a surrogate measure of broader health care quality.
    The Centers for Medicare and Medicaid Services recently announced that hospitals must soon report surgical site infection rates for select procedures. Failing to meet benchmarks will result in financial penalties. But Makary says that the new requirement covers only a small number of procedures and wider reporting of complications will initially be voluntary. Makary says Medicare needs to quickly expand the program and speed up the transition to uniform public reporting for all hospitals.
    In the new study, Makary and his colleagues found that, as of September 2010, 29 states had no laws regarding the monitoring and reporting of surgical site infections. Of the 21 that did have such laws, only eight made the data publicly available in an easy-to-access format.
    Even then, he said, the data shared are limited, covering between two and seven procedures. Seven of the eight states reported surgical site infection rates following coronary artery bypass graft procedures, six did so for knee or hip replacement surgeries, and two reported rates after colon surgery, which nationally has the highest rates of surgical site infections. Only one state, Ohio, reported rates after gallbladder surgery, among the most common surgical procedures in the United States. The average time lag between collection and publication of data was six months, with a range of two to 11 months.
    Makary also says that states don’t always specify how data are to be collected, resulting in lack of uniform reporting that can make comparisons impossible. The lack of national standards, he says, may also disadvantage hospitals that are better at collecting information, because their rates may appear higher than those at hospitals that don’t look as rigorously for infection cases.
    “It is important to use a common method or at a minimum ensure common parameters, inputs and definitions are used,” he says. “Without that, it is difficult for consumers, payers or regulators to compare infections within or across states. Unless we are comparing apples to apples, public disclosure has the potential to mislead patients instead of help them.”

    Wednesday, February 29, 2012

    abstManagement-changing errors in the recall of radiologic results — A pilot study Clinical Radiology



    Management-changing errors in the recall of radiologic results — A pilot study

    Aim
    To evaluate the occurrence of alterations to diagnostic information from radiological studies, which are altered by person-to-person communication and/or faulty recall, and whether they affect patient management

    Materials and methods

    A structured telephone survey was conducted at a large tertiary care medical centre of house staff managing inpatients who had undergone chest, abdominal, or pelvic computed tomography (CT) or magnetic resonance imaging (MRI) and remained in the hospital at least 2 days later.  

    Fifty-six physicians were surveyed regarding 98 patient cases. Each physician was asked how he or she first became aware of the results of the study. Each was then asked to recall the substance of radiological interpretation and to compare it with the radiology report. Each was then asked to assess the level of difference between the interpretations and whether management was affected. Results were correlated with the route by which interviewees became aware of the report, the report length, and whether the managing service was medical or surgical.

    Results

    In nearly 15% (14/98) of cases, differences between the recalled and official results were such that patient management could have been (11.2%) or had already been affected (3.1%). There was no significant correlation between errors and either the route of report communication or the report length.

    Conclusion

    There was a substantial rate of error in the recall and/or transmission of diagnostic radiological information, which was sufficiently severe to affect patient management.

    Wednesday, February 01, 2012

    open access: Hospital Survey on Patient Safety Culture 2012 User Comparative Database Report (U.S.)



    Hospital Survey on Patient Safety Culture

    2012 User Comparative Database Report


    Based on data from 1,128 U.S. hospitals, the Hospital Survey on Patient Safety Culture: 2012 User Comparative Database Report provides initial results that hospitals can use to compare their patient safety culture to other U.S. hospitals. In addition, the 2012 report presents results showing change over time for 650 hospitals that submitted data more than once. The report consists of a narrative description of the findings and four appendixes, presenting data by hospital characteristics and respondent characteristics for the database hospitals overall and separately for the 650 trending hospitals.
    Select to download print version (Part 1, PDF File, 1.8 MB; Parts 2 and 3, PDF File, 1.6 MB). PDF Help.

    The Agency for Healthcare Research and Quality (AHRQ) released the Hospital Survey on Patient Safety Culture, a tool to help hospitals evaluate how well they had established a culture of safety

    Sunday, January 29, 2012

    abstract: Predictors of prescription errors involving anticancer chemotherapy agents (note: carboplatin)



    Blogger's note: stats removed for ease of reading

    Aim

    The majority of medication errors that harm patients relate to the prescribing process. Our study aimed to identify the predictors of prescription errors involving anticancer chemotherapy agents.

    Methods

    All consecutive antineoplastic prescriptions from June 2006 to May 2008 were analysed, with medication errors being captured. Potential risk factors for medication prescribing errors were defined in relation to the patient, chemotherapy regimen and hospital organisation. The relationship between these risk factors and observed medication errors or dose medication errors was assessed by univariate and multivariate logistic-regression analyses.

    Results

    Among the 17,150 chemotherapy prescriptions, 540 contained at least one error (3.15%). The following independent predictors of risk of medication errors were identified: patients with a body surface area , protocols with more than three drugs , protocols involving carboplatin, protocols requiring at least one modification by the physician, inpatient care  and prescriptions by a resident physician. The risk of medication dose prescribing errors was significantly associated with three independent factors: protocols involving carboplatin  protocols with more than three drugs and protocols requiring at least one modification.

    Conclusion

    In this epidemiologic study, the independent risk factors identified should be targeted for preventive measures in order to improve anticancer agent prescriptions and reduce the risk of medication errors.